This document establishes the updated fee structure for the licensing and regulation of medicinal products for human use within the United Kingdom. The regulations were issued by the government of Great Britain to adjust the financial obligations imposed on pharmaceutical entities. This legal instrument serves to amend existing statutory requirements to ensure the administrative costs of medicinal oversight are recovered through specific fee schedules.

Legal professionals and regulatory compliance officers utilize this text as a primary source for historical administrative law. It is regarded as a technical, highly specific document intended for use within the context of UK pharmaceutical regulation.